Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 - Sterling - 2020 - American Journal of Transplantation - Wiley Online Library
Pharmacotherapy: Treatment of Tuberculosis and Multidrug-Resistant Tuberculosis - YouTube
Latent TB Treatment: Shorter is Better | McGill University Health Centre
Patient Information Brochure
12-dose Isoniazid (INH)/Rifapentine Regimen (3HP) for Treatment of Latent TB Intection (LTBI)
LTBI | Features | TB | CDC
![PDF] Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a2ee1f61e0a600c39cca40a353e6251f6205dc9f/4-Table2-1.png "PDF] Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy | Semantic Scholar")
PDF] Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy | Semantic Scholar
3HP for Latent TB Infection Treatment | CDC
CDC Recommends New Treatment Regimen for Latent Mycobacterium Tuberculosis Infection | AAFP
What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine | National Prevention Information Network | Connecting public health professionals with trusted information and each other
12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Chapter 5.1 Recommended dosages of TPT medication | TB Knowledge Sharing
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan - ScienceDirect
Treatment of latent tuberculosis infection | Semantic Scholar
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Treating Latent Tuberculosis - YouTube
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection | NEJM
Chapter 5.1 Recommended dosages of TPT medication | TB Knowledge Sharing
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society
Table 3 from Treatment of Latent Tuberculosis Infection. | Semantic Scholar
1.4. Tuberculosis preventive treatment options | TB Knowledge Sharing
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
